European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. [electronic resource]
Producer: 20200825Description: 966-984 p. digitalISSN:- 1476-5551
- Aniline Compounds -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Clinical Decision-Making
- Consensus Development Conferences as Topic
- Dasatinib -- therapeutic use
- Disease Management
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Gene Expression
- Humans
- Imatinib Mesylate -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- diagnosis
- Life Expectancy -- trends
- Monitoring, Physiologic
- Nitriles -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Quality of Life
- Quinolines -- therapeutic use
- Survival Analysis
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.